Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2- Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication.

Riccardo Giovanni BorroniMichela BartoliniMariangela GaudioFlavia JacobsChiara BenvenutiRiccardo GerosaPaola TiberioSofia Ada Assunta Maria ManaraAlessandra SolferinoArmando SantoroRita De Sanctis

Published in: The oncologist (2024)

We mapped frequency and types of ribociclib-induced CAEs. An interdisciplinary management of CAEs incorporated into routine care may reduce the rate of drug discontinuation thus potentially contributing to better long-term outcomes.

Keyphrases

high glucose
diabetic rats
drug induced
healthcare
squamous cell carcinoma
quality improvement
endothelial cells
emergency department
health insurance
electronic health record